GAD1 and cerebellar ataxia: Although proven later to be a particularly rare entity, affecting about 2% of patients with sporadic cerebellar ataxia [21], anti-GAD antibody-associated cerebellar ataxia represents the second most frequent phenotype of GAD-related disease on the spectrum [11].